C.Q. Pharmaceutical Holding Future Growth
Future criteria checks 3/6
C.Q. Pharmaceutical Holding is forecast to grow earnings and revenue by 38.9% and 13.5% per annum respectively while EPS is expected to grow by 39% per annum.
Key information
38.9%
Earnings growth rate
39.0%
EPS growth rate
Healthcare earnings growth | 21.6% |
Revenue growth rate | 13.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 101,654 | 1,291 | N/A | 856 | 1 |
12/31/2024 | 90,583 | 1,105 | N/A | 1,417 | 1 |
3/31/2024 | 80,123 | 592 | 208 | 451 | N/A |
12/31/2023 | 80,119 | 655 | 264 | 509 | N/A |
9/30/2023 | 75,682 | 690 | 1,009 | 1,201 | N/A |
6/30/2023 | 75,869 | 1,065 | -759 | -536 | N/A |
3/31/2023 | 71,571 | 1,006 | 117 | 351 | N/A |
1/1/2023 | 67,829 | 952 | 18 | 286 | N/A |
9/30/2022 | 66,833 | 1,104 | -1,196 | -790 | N/A |
6/30/2022 | 65,084 | 969 | -459 | -21 | N/A |
3/31/2022 | 63,938 | 1,038 | -841 | -361 | N/A |
12/31/2021 | 62,521 | 1,005 | -239 | 250 | N/A |
9/30/2021 | 61,022 | 954 | -1,584 | -1,125 | N/A |
6/30/2021 | 58,266 | 1,022 | -1,122 | -643 | N/A |
3/31/2021 | 52,016 | 880 | -310 | 112 | N/A |
12/31/2020 | 45,220 | 884 | 254 | 632 | N/A |
9/30/2020 | 39,096 | 755 | 398 | 868 | N/A |
6/30/2020 | 34,703 | 624 | 75 | 589 | N/A |
3/31/2020 | 33,599 | 726 | -932 | -252 | N/A |
12/31/2019 | 33,844 | 788 | -619 | 202 | N/A |
9/30/2019 | 32,536 | 888 | -2,453 | -1,674 | N/A |
6/30/2019 | 29,897 | 844 | -2,293 | -1,656 | N/A |
3/31/2019 | 27,641 | 700 | -2,262 | -1,786 | N/A |
12/31/2018 | 25,803 | 691 | -2,010 | -1,706 | N/A |
9/30/2018 | 22,021 | 123 | -2,017 | -1,900 | N/A |
6/30/2018 | 21,501 | 715 | -2,147 | -1,998 | N/A |
3/31/2018 | 21,385 | 613 | -1,711 | -1,572 | N/A |
12/31/2017 | 21,190 | 590 | N/A | -1,102 | N/A |
9/30/2017 | 19,170 | 1,723 | N/A | -379 | N/A |
12/31/2016 | 20,487 | 956 | N/A | -307 | N/A |
12/31/2015 | 19,419 | 394 | N/A | 227 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000950's forecast earnings growth (38.9% per year) is above the savings rate (2.9%).
Earnings vs Market: 000950's earnings (38.9% per year) are forecast to grow faster than the CN market (22% per year).
High Growth Earnings: 000950's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 000950's revenue (13.5% per year) is forecast to grow slower than the CN market (13.5% per year).
High Growth Revenue: 000950's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 000950's Return on Equity is forecast to be high in 3 years time